Microsomal triglyceride transfer protein polymorphisms and lipoprotein levels in type 2 diabetes

QJM: An International Journal of Medicine

Volumn 97, Issue 4, 2004, Pages 211-218

  Phillips, C ^a   Mullan, K ^a   Owens, D ^a   Tomkin, G H ^a,b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b NONE   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CHOLESTEROL; CHYLOMICRON; DNA; GUANINE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PHOSPHOLIPID; THYMINE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); FAT INTAKE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIVER LEVEL; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEIC ACID BASE SUBSTITUTION; PHOSPHOLIPID BLOOD LEVEL; POLYMERASE CHAIN REACTION; POSTPRANDIAL STATE; PRIORITY JOURNAL; REGULATORY MECHANISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 1842834052     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hch040     Document Type: Article

References (29)

1. Tomkin GH, Owens D. ApoB lipoproteins, diabetes and atherosclerosis. Diabetes Metabol Res Rev 2001; 17:27-43.
2. Koba S, Hirano T, Murayama S, Kotani T, Tsunoda Y, Iso Y, Ban Y, Kondo T, Suzuki H, Katagiri T. Small dense LDL phenotype is associated with postprandial increases of large VLDL and remnant-like particles in patients with acute myocardial infarction. Atherosclerosis 2003; 170:131-40.
3. Packard CJ, Demant T, Stewart JP, Bedford D, Caslake MJ, Schwertfeger G, Bedynek A, Shepherd J, Seidel D. Apoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res 2000; 41:305-17.
4. Duvillard L, Pont F, Florentin E, Galland-Jos C, Gambert P, Verges B. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study. Eur J Clin Invest 2000; 30:685-94.
5. Curtin A, Deegan P, Owens D, Collins P, Johnson A, Tomkin GH. Elevated triglyceride-rich lipoproteins in diabetes: a study of apolipoprotein B48. Acta Diabetologica 1996; 33:205-10.
6. Taggart C, Gibney J, Owens D, Collins P, Johnson A, Tomkin GH. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes. Diabet Med 1997; 14:1051-8.
7. McEneny J, O'Kane JM, McMaster D, Mercer C, Trimble ER, Young IS. Very low density lipoprotein subfractions in type 2 diabetes mellitus: alterations in composition and suceptibility to oxidation. Diabetologia 2000; 43:485-93.
8. Phillips C, Murugasu G, Owens D, Collins P, Johnson A, Tomkin GH. Improved metabolic control reduces the number of postprandial apolipoprotein B48-containing particles in type 2 diabetes. Atherosclerosis 2000; 148:283-91.
9. Mero N, Malmstrom R, Steiner G, Taskinen MR, Syvanne M. Postprandial metabolism of apolipoprotein B-48- and B-100 containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis 2000; 150:167-77.
10. Hussein MM. A proposed model for the assembly of chylomicrons. Atherosclerosis 2000; 148:1-15.
11. Gleeson A, Anderton K, Owens D, Bennett A, Collins P, Johnson A, White D, Tomkin GH. The Role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes. Diabetologia 1999;42:944-9.
12. Phillips C, Anderton K, Bennett A, Owens D, Collins P, Johnson A, Tomkin GH. Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidaemia in diabetes. Metabolism 2002; 51:847-52.
13. Phillips C, Owens D, Collins P, Tomkin GH. Altered expression of microsomal triglyceride transfer protein and increased lymph chylomicron production in the insulin resistant zucker obese fa/fa rat. Atherosclerosis 2002; 160:355-60.
14. Mamo JCL, Proctor SD, Smith D, Retention of chylomicron remnants by arterial tissue: importance of an efficient clearance mechanism from plasma. Atherosclerosis 1998; 141 (Suppl. 1): S63-9.
15. Bernard S, Touzet S, Personne I, Lapras V, Bondon PJ, Berthezene F, Moulin P. Association between microsomal triglyceride transfer protein gene polymorphism and biological features of liver steatosis in patients with type 2 diabetes. Diabetologia 2000; 43:995-9.
16. Chen SPL, Tan KCB, Lam KSL. Effect of the microsomal triglyceride transfter protein -493 polymorphism and type 2 diabetes mellitus on LDL subfractions. Atherosclerosis 2003; 167:287-92.
17. Karpe F, Lundahl B, Ehrenborg E, Eriksson P, Hamsten A. A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. Atheroscler Thromb Vasc Biol 1998; 18:756-61.
18. St-Pierre J, Lemieux I, Millar-Felix I, Prud'homme D, Bergeron J, Gaudet D, Nadeau A, Despres J-P, Vohl MC, Viceral obesity and hyperinsulinaemia modulate the impact of the microsomal triglyceride transfer protein -493G/T polymorphism on plasma lipoprotein levels in men. Atherosclerosis 2002; 160:317-24.
19. Juo S-HH, Han Z, Smith JD, Colangelo L, Lui K. Common polymorphism in the promoter of the microsomal triglyceride transfer protein gene influences cholesterol, apo B, and triglyceride levels in young African American men. Results from the Corronary artery risk development in young adults (CARDIA) Study. Arterioscler Thromb Vasc Biol 2000; 20:1316-22.
20. Lundahl B, Hamsten A, Karpe F. Postprandial plasma ApoB-48 levels are influenced by a polymorphism in the promoter of the microsomal triglyceride transfer protein gene. Arterioscler Thromb Vasc Biol 2002; 22:289-93.
21. Herrmann SM, Poirier O, Nicaud V, Evans A, Ruidavets JB, Arveiler D, Bao Seng C, Cambien F. Identification of two polymorphisms of the microsomal triglyceride transfer protein gene: lack of association with lipoprotein profiles. J Lipid Res 1998; 39:2432-5.
22. Ledmyr H, Karpe F, Lundahl B, NcKinnon M. Skoglund-Andersson C, Ehrenborg E. Varients of the microsomal triglyceride transfer protein gene are associated with plasma cholesterol levels and body mass index. J Lipid Res 2002; 43:51-8.
23. Havel RA, Eder HM, Bragden JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34:1345-53.
24. Karpe F, Hamsten A. Determination of apolipoproteins B48 and B100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J Lipid Res 1994; 35:1311-17.
25. Wenham PR, Newton CR, Price WH. Analysis of apolipoprotein E genotypes by the Amplification Refractory Mutation System. Clin Chem 1991; 37:241-4.
26. Lundahl B, Hamsten A, Karpe F. Postprandial plasma apo B48 levels are influenced by a polymorphism in the promoter of the microsomai triglyceride transfer gene. Atheroscler Thromb Vasc Biol 2002; 22:289-93.
27. Sheehan D, Bennett T, Cashman. Apolipoprotein E polymorphisms and serum cholesterol in healthy Irish adults: a proposed genetic marker for coronary artery disease risk. Ir J Med Sci 2000; 169:50-4.
28. Gianturco S, Ramprasad M, Song R, Li R, Brown M, Bradley W. Apolipoprotein B48 or its apolipoprotein B100 equivalent mediates binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage receptor. Arterioscler Thromb Vasc Biol 1998; 18:968-76.
29. Taskinen M-R. Diabetic dyslipidaemia, from basic research to clinical practice. Diabetologia 2003; 46:733-49.